GLP1R and type 2 diabetes mellitus: In parallel, expression of TCF7L2 as well as the GLP-1 receptor (GLP-1R) and GIP receptor (GIPR) was also decreased in islets from humans with T2D as well as in isolated human islets depleted of TCF7L2 via siRNA treatment [17].